Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 23%
Buy 15%
Hold 54%
Sell 8%
Strong Sell 0%

Bulls say

Universal Health Services has demonstrated significant financial improvement, with the Acute Care Hospital Services segment reporting a substantial increase in adjusted EBITDA margin by 190 basis points to 15.8%. The Behavioral Health Services segment also showed positive momentum, with revenue growth of 9.3%, indicating a rebound in patient volumes, as evidenced by an increase in adjusted patient days. Moreover, the company's positive outlook is bolstered by prospective programs awaiting CMS approval that could potentially add $75-80 million to revenue, alongside expectations for improved margins driven by easing labor costs and enhanced operational efficiencies.

Bears say

The negative outlook on Universal Health Services Inc. is primarily driven by anticipated volume and margin headwinds that are expected to impact fiscal year 2026 earnings, with estimates projected to be approximately 5% below expectations and an enterprise multiple reflecting trough levels observed in 2024 at around 5.5x. Additionally, the company's behavioral health segment is experiencing soft volume trends, exacerbated by a downward adjustment in long-term growth projections, with behavioral volumes expected to grow at only 2% through 2026. Furthermore, a significant decline in the contribution from DPP to EBITDA is projected for 2028, with a potential impact estimated between $420 million to $470 million over the following four years, amplifying the financial uncertainty for the firm moving forward.

UHS has been analyzed by 13 analysts, with a consensus rating of Hold. 23% of analysts recommend a Strong Buy, 15% recommend Buy, 54% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Hold based on their latest research and market trends.

According to 13 analysts, UHS has a Hold consensus rating as of Jan 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $232.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $232.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.